Akèy › Leksemi mieloïd egi › New York › New Rochelle
Etid klinik pou Leksemi mieloïd egi nan New Rochelle, NY
13 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote New Rochelle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- North Shore University Hospital, Manhasset · 9 mi lwen
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Ap rekriteFaz 1
- Memorial Sloan Kettering Westchester, Harrison · 5 mi lwen
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester, Harrison · 5 mi lwen
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester, Harrison · 5 mi lwen
- North Shore University Hospital, Manhasset · 9 mi lwen
A Study of CRD3874-SI in People With Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison · 5 mi lwen
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- North Shore University Hospital, Manhasset · 9 mi lwen
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of Revumenib and Mezigdomide in People With Leukemia
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 1
- Memorial Sloan Kettering Westchester, Harrison · 5 mi lwen
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Seattle, WA41 etid
- Baldwin Park, CA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA31 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan New Rochelle
- Kansè nan tete38 etid
- Kansè Poumon ki pa ti selil18 etid
- Kansè pwostat16 etid
- Myelom Miltip14 etid
- Kansè vejik11 etid
- Kansè poumon11 etid
- Kansè Endomèt11 etid
- Kansè Metastatik10 etid
- Kansè (tout kalite)10 etid
- Kansè ovè9 etid
- Maladi kadyovaskilè8 etid
- Kansè pankreyas8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.